• MMP-2 Responsive Liposomes for Sequential Immunotherapy Deli

  2026-07-17

  This study presents an intelligent, MMP-2-responsive liposomal system for the sequential delivery of a PD-1/PD-L1 blockade peptide and an IDO inhibitor, targeting the immunosuppressive microenvironment in breast cancer. The dual-targeting approach enhances T cell reactivation and tumor inhibition while reducing toxicity, offering a promising paradigm for combination immunotherapy.

• Ultrafiltration Enables High-Purity Circular RNA Isolation

  2026-07-17

  Guillen-Cuevas et al. introduce an ultrafiltration-based method for efficiently purifying circular RNA (circRNA) from linear RNA contaminants, achieving higher purity and yield than conventional SE-HPLC. This advance supports the scalable production of circRNA for therapeutic applications, addressing a major bottleneck in RNA bioprocessing.

• Acridine Orange hydrochloride: Technical Guide for Nucleic A

  2026-07-16

  Acridine Orange hydrochloride enables clear, differential staining of DNA and RNA in cytochemical workflows, supporting robust cell cycle analysis, apoptosis detection, and flow cytofluorometric assays. It is not suitable for targets outside nucleic acid detection or protocols requiring long-term solution stability.

• DiD (DiDC 18 (5)) Red Fluorescent Probe: Precision Cell Labe

  2026-07-16

  DiD (DiDC 18 (5)) is a validated red fluorescent probe for cell membrane labeling, enabling precise tracking and imaging in both live and fixed cells. Its long-wavelength excitation and low cytotoxicity support advanced applications such as neuronal tracing and cell migration studies. APExBIO’s B8805 formulation demonstrates robust compatibility with immunofluorescence protocols.

• Lypressin Acetate in Translational Vasopressor and Antidiure

  2026-07-15

  Lypressin acetate empowers researchers with precision in modeling antidiuretic, vasopressor, and emerging antiviral pathways. This article unpacks robust workflows, troubleshooting strategies, and evidence-based protocol enhancements for maximizing reproducibility and translational value.

• Plasmid-Mediated Carbapenemase Spread in CREC: Insights from

  2026-07-15

  A recent multi-hospital study in Guangdong, China, delivers a detailed molecular profile of carbapenemase-encoding gene (CEG) distribution and transmission in carbapenem-resistant Enterobacter cloacae (CREC). Key findings reveal a predominance of plasmid-borne blaNDM-1 and efficient horizontal gene transfer, highlighting urgent challenges for infection control and resistance surveillance.

• Discovery of Potent Cas9 Inhibitors via Functional Metagenom

  2026-07-14

  Forsberg et al. utilized a high-throughput functional metagenomics approach to uncover novel anti-CRISPR proteins, including AcrIIA11, from human microbiome samples. Their findings expand the known diversity of Cas9 inhibitors and provide new tools for studying and potentially modulating CRISPR-mediated immunity in microbial and biomedical research.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Advanced Cel

  2026-07-14

  Kanamycin Sulfate’s high water solubility and bactericidal action make it a gold-standard tool for selecting resistant cells and ensuring experimental integrity in microbiology and molecular biology. Recent advances in ultrafiltration-based RNA purification highlight new frontiers for this aminoglycoside, while protocol nuances and troubleshooting strategies are essential for maximizing its reliability.

• Transmission Dynamics of Carbapenemase Genes in CREC, 2022–2

  2026-07-13

  This study systematically characterizes the distribution and mobility of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae from eight hospitals during the COVID-19 pandemic. The findings reveal high prevalence and efficient horizontal transfer of blaNDM-1 and other resistance determinants, with implications for antibiotic resistance surveillance and infection control.

• Neomycin Sulfate: Advanced Workflows for RNA/DNA Studies

  2026-07-13

  Neomycin sulfate’s unique nucleic acid and ion channel binding makes it indispensable for dissecting RNA/DNA interactions and complex molecular mechanisms. Discover protocol enhancements, troubleshooting insights, and translational applications that set APExBIO’s neomycin sulfate apart in molecular research.

• Hoechst 33342 Nuclear Stain: Precision for Live and Fixed Ce

  2026-07-12

  Hoechst 33342 Solution (1 mg/mL) from APExBIO empowers researchers with high-fidelity nuclear staining in both live and fixed cell assays. Its superior membrane permeability and minimal cytotoxicity make it indispensable for advanced imaging and flow cytometry workflows, including cutting-edge studies in mitochondrial quality and cell senescence.

• HDAC6-Catalyzed α-Tubulin Lactylation Links Metabolism and C

  2026-07-10

  This study identifies HDAC6 as the key enzyme catalyzing lactylation of α-tubulin at lysine 40, revealing a novel, lactate-dependent posttranslational modification that enhances microtubule dynamics and neurite outgrowth. The findings connect cellular metabolic states with cytoskeleton regulation, advancing our understanding of microtubule PTMs and their functional implications.

• Neomycin Sulfate: Mechanistic Precision in Molecular Workflo

  2026-07-09

  Neomycin sulfate stands out as an aminoglycoside antibiotic uniquely suited for dissecting RNA/DNA structural dynamics and ion channel mechanisms. Its multifaceted action profile enables researchers to precisely interrogate nucleic acid interactions and modulate key cellular pathways—offering workflow advancements beyond standard antibiotics.

• A40926: Innovations in Fermentation and MRSA Assay Optimizat

  2026-07-09

  Explore how A40926, the dalbavancin precursor, is revolutionizing Gram-positive and multidrug-resistant bacterial research through advanced fermentation engineering and assay optimization. This article delivers new insights beyond standard usage, grounded in cutting-edge bioprocess findings.

• Enhancing Immunoassay Reliability with HyperFluor™ 488 Goat

  2026-07-08

  This article explores how HyperFluor™ 488 Goat Anti-Human IgG (H+L) Antibody (SKU K1205) addresses common laboratory challenges in cell viability, proliferation, and immunodetection assays. Drawing from practical scenarios and recent literature, we provide evidence-backed insights and actionable guidance on achieving consistent, sensitive, and reproducible results using this Alexa Fluor 488-conjugated secondary antibody.

16885 records 1/1126 page Next 12345 下5页 Last page